Gram negative bacteria (Facultative Anaerobic Gram-Negative Rods) 1st part

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/107

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

108 Terms

1
New cards

Family Enterobacteriaceae

A large family of Gram-negative, facultative anaerobic, non-spore-forming rods commonly found in the

gastrointestinal tract of humans and animals.

2
New cards

Fimbriae (Pili)

Many members possess — that aid in attachment to host mucosal surfaces, which is crucial for colonization and infection.

3
New cards

Sex Pili

Some strains have —, specialized structures that facilitate bacterial conjugation — a process where plasmid DNA, often containing antibiotic resistance genes (R plasmids), is transferred from one bacterium to another.

4
New cards

Family Enterobacteriaceae

Known for their antigenic diversity (e.g., O, H, K antigens) and ability to cause opportunistic and nosocomial infections.

5
New cards

Family Enterobacteriaceae

Includes both pathogenic (e.g., Salmonella, Shigella, Escherichia coli, Yersinia) and commensal organisms (e.g., Enterobacter, Klebsiella, Proteus).

6
New cards

Lives in the intestinal tract of humans and warm-blooded animals.

common habitat for Escherichia coli

7
New cards

Produces acid and gas, used in laboratory diagnostics and water contamination testing.

General Characteristics of Escherichia coli (Ferments Lactose)

8
New cards

O antigen, H antigen, K antigen

Antigenic structure of Escherichia Coli:

9
New cards

O antigen

Lipopolysaccharide (cell wall).

10
New cards

H antigen

Flagellar

11
New cards

K antigen

Capsular polysaccharide.

12
New cards

fimbriae, toxins, conjugation (sex pili)

virulence factors of Escherichia coli

13
New cards

Fimbriae

Attachment to host epithelial cells.

14
New cards

Toxins

Depending on strain, may produce enterotoxins or Shiga-like —.

15
New cards

Conjugation (Sex Pili)

DNA exchange—can spread antibiotic resistance

16
New cards

Urinary Tract Infection (UTI), Traveler’s Diarrhea, E. coli O157:H7 Infection (Enterohemorrhagic E. coli)

diseases of Escherichia Coli:

17
New cards

Escherichia Coli

common pathology to humans

18
New cards

Escherichia Coli

causes UTI

19
New cards

Dysuria, urgency, frequency, cloudy or bloody urine; severe cases may lead to bacteremia.

symptoms of UTI

20
New cards

Dysuria

inability to urinate

21
New cards

Polyuria

cloudy or bloody urine

22
New cards

Mild cases may self-resolve; Common antibiotics (Ciprofloxacin, Trimethoprim-Sulfamethoxazole (TMP-SMX), Nitrofurantoin); Based on urine culture and sensitivity testing.

Treatments of UTI:

23
New cards

Ciprofloxacin, Trimethoprim-Sulfamethoxazole (TMP-SMX), Nitrofurantoin

Antibiotics for UTI:

24
New cards

Traveler’s Diarrhea

Often caused by Enterotoxigenic E. coli (ETEC).

25
New cards

Enterotoxigenic E. coli (ETEC)

Travelers Diarrhea is caused by —

26
New cards

Fecal-oral route; ingestion of contaminated food or water.

Transmission of travelers disease

27
New cards

Nausea, vomiting, watery diarrhea, abdominal cramps (1–3 days).

Symptoms of Travelers Disease

28
New cards

Streptomycin

drug for travelers disease

29
New cards

Streptomycin

Effective against ETEC and other enteric pathogens.

30
New cards

Streptomycin, Primary treatment includes fluid and electrolyte replacement, Avoid dairy products during illness.

Treatment of Travelers disease:

31
New cards

Shiga toxins (Stx1, Stx2)

Toxin of E. coli O157:H7 Infection (Enterohemorrhagic E. coli)

32
New cards

Bloody diarrhea, Hemorrhagic colitis, Hemolytic Uremic Syndrome (HUS) – triad: hemolytic anemia, thrombocytopenia, acute renal failure

Symptoms of E. coli O157:H7 (Enterohemorrhagic E. coli)

33
New cards

hemolytic anemia, thrombocytopenia, acute renal failure

Hemolytic Uremic Syndrome (HUS) – triad:

34
New cards

No antibiotics or antidiarrheals, Supportive therapy: fluid/electrolyte replacement.

Treatment for E.coli O157:H7 (Enterohemorrhagic E.coli):

35
New cards

ETEC (Enterotoxigenic), EPEC (Enteropathogenic), EIEC (Enteroinvasive), EHEC (Enterohemorrhagic

/ VTEC), EAEC (Enteroaggregative), DAEC (Diffusely Adherent)

Pathogenic Groups of E. coli:

36
New cards

Heat-labile (LT) and Heat-stable (ST) toxins

Virulence Factors of ETEC (Enterotoxigenic):

37
New cards

Attaching and effacing lesions

Virulence Factors of EPEC (Enteropathogenic)

38
New cards

Invasion of epithelial cells

Virulence Factors of EIEC (Enteroinvasive)

39
New cards

Shiga toxins (Stx1, Stx2)

Virulence Factors of EHEC (Enterohemorrhagic/ VTEC)

40
New cards

Biofilm formation, toxins

Virulence Factors of EAEC (Enteroaggregative)

41
New cards

Diffuse adherence to cells

Virulence Factors of DAEC (Diffusely Adherent)

42
New cards

Traveler's diarrhea

Disease of ETEC (Enterotoxigenic)

43
New cards

Infantile diarrhea

Disease of EPEC (Enteropathogenic)

44
New cards

Dysentery-like illness

Disease of EIEC (Enteroinvasive)

45
New cards

Hemorrhagic colitis, HUS

Disease of EHEC (Enterohemorrhagic / VTEC)

46
New cards

Persistent diarrhea

Disease of EAEC (Enteroaggregative)

47
New cards

Diarrhea

Disease of DAEC (Diffusely Adherent)

48
New cards

Watery diarrhea, nausea, cramps

Clinical Features of ETEC (Enterotoxigenic) (Traveler's diarrhea)

49
New cards

Watery diarrhea, mucus, dehydration

Clinical Features of EPEC (Enteropathogenic) (Infantile diarrhea)

50
New cards

Bloody diarrhea, fever, pain

Clinical Features of EIEC (Enteroinvasive) (Dysentery-like illness)

51
New cards

Bloody diarrhea, abdominal cramps

Clinical Features of EHEC (Enterohemorrhagic/ VTEC) (Hemorrhagic colitis, HUS)

52
New cards

Especially in children and immunocompromised

Clinical Features of EAEC (Enteroaggregative) (Persistent diarrhea)

53
New cards

Mostly in children

Clinical Features of DAEC (Diffusely Adherent) (Diarrhea)

54
New cards

Lactose fermentation, IMViC tests, Serotyping

Laboratory Diagnosis of E.coli O157:H7 (Enterohemorrhagic E.coli)

55
New cards

Lactose fermentation

Positive (MacConkey agar – pink colonies)

56
New cards

IMViC tests

Indole (+), Methyl Red (+), Voges-Proskauer (-), Citrate (-)

57
New cards

Serotyping

Used for identification of pathogenic strains (e.g., O157:H7)

58
New cards

Azithromycin

drug of choice of travelers diarrhea

59
New cards

BRAT (Banana, Rice, Apple, Toasted bread)

travelers diarrhe treatment (food)

60
New cards

Inhabit the gastrointestinal tract (GIT) of animals and can be transmitted to humans through contaminated food and water.

Common Habitat of Salmonella

61
New cards

S. typhi, S. paratyphi

2 kinds Salmonella:

62
New cards

Typhoid Fever, Salmonellosis

diseases of Salmonella:

63
New cards

Salmonella enterica serotypes

Causative Agents of Typhoid Fever

64
New cards

Ingestion of contaminated food or water

Portal of Entry of Salmonella:

65
New cards

Prolonged fever; Headache, muscle pain, malaise; Rose-colored spots on the abdomen

Symptoms of Typhoid fever:

66
New cards

Chloramphenicol, Ampicillin, Ciprofloxacin

Treatment of Salmonella:

67
New cards

Various Salmonella enterica serotypes (e.g., S. Enteritidis, S. Typhimurium)

Causative Agents for Salmonellosis:

68
New cards

Ingestion of undercooked or contaminated meat, eggs, dairy; Contact with infected animals or environment

Portal of Entry of Salmonellosis:

69
New cards

Non-bloody diarrhea, Vomiting, Fever, Headache

Symptoms of Salmonellosis:

70
New cards

Supportive care (oral rehydration, electrolyte replacement), Antibiotics for severe or complicated cases (Ciprofloxacin)

Treatment for salmonellosis:

71
New cards

Ciprofloxacin

Antibiotic for Salmonellosis

72
New cards

Shigella

Gram-negative, non-motile, non-lactose fermenting, facultative anaerobes

73
New cards

Shigella

Reservoir: Humans only (no animal reservoir)

74
New cards

Shigella

Causes shigellosis (bacillary dysentery), a form of inflammatory diarrhea

75
New cards

shigellosis (bacillary dysentery)

Shigella causes — a form of inflammatory diarrhea

76
New cards

Shigella dysenteriae, Shigella flexneri, Shigella boydii, Shigella sonnei

Causative Agents (Species of Shigella)

77
New cards

Shigella dysenteriae

Most severe form; produces Shiga toxin; can cause epidemics and HUS

78
New cards

Shigella flexneri

Most common in developing countries; causes moderate to severe disease

79
New cards

Shigella boydii

Less common; mostly found in South Asia

80
New cards

Shigella sonnei

Most common in developed countries; causes milder disease

81
New cards

Fecal-oral route, Highly contagious, Common in overcrowded areas with poor sanitation

Transmission of Shigella:

82
New cards

Gastrointestinal tract via contaminated hands, food, water

portal of entry of Shigella:

83
New cards

Invades and multiplies in colonic epithelial cells, Induces inflammatory response → tissue damage, Some strains (especially S. dysenteriae) produce Shiga toxin, which:

o Inhibits protein synthesis

o Causes cell death

o May lead to hemolytic uremic syndrome (HUS)

pathogenisis of Shigella:

84
New cards

Shigella dysenteriae

produce Shiga toxin, which:

o Inhibits protein synthesis

o Causes cell death

o May lead to hemolytic uremic syndrome (HUS)

85
New cards

Purulent, bloody diarrhea, Crampy abdominal or rectal pain, Tenesmus, Fever, Nausea and vomiting

Symptoms of Shigellosis:

86
New cards

Severe dehydration, Febrile seizures (especially in children), Hemolytic Uremic Syndrome (HUS) – particularly with S. dysenteriae, Toxic megacolon or intestinal perforation (rare but serious)

Complications of Shigella:

87
New cards

Mild cases may resolve on their own with supportive care, Moderate to severe cases or outbreaks require antibiotics, Antibiotic Options (based on susceptibility testing):

• Ciprofloxacin

• Azithromycin

• Rifaximin (not for invasive strains)

• Ceftriaxone (especially in severe pediatric cases)

Treatment for Shigella

88
New cards

Ciprofloxacin, Azithromycin, Rifaximin, Ceftriaxone

Antibiotics for Shigella:

89
New cards

Proper hand hygiene, Safe food and water practices, Sanitation and public health education, No widely used vaccine yet (under development)

Prevention of Shigella:

90
New cards

Klebsiella

Gram-negative, nonmotile, capsulated, facultative anaerobes

91
New cards

Klebsiella

Known for causing opportunistic and healthcare-associated (nosocomial) infections

92
New cards

Nonmotile, Capsule Production: Prominent polysaccharide capsule

general characteristics of Klebsiella:

93
New cards

Nonmotile

Does not possess flagella for movement.

94
New cards

Capsule Production: Prominent polysaccharide capsule:

o Inhibits phagocytosis

o Enhances virulence

o Gives colonies a mucoid appearance on agar

95
New cards

Urinary Tract Infections (UTIs); Respiratory Tract Infections; Wound Infections; Bloodstream Infections; Liver abscess, meningitis

Pathogenic Capabilities Common Infections of Klebsiella:

96
New cards

purulent

puss and mucus

97
New cards

tenesmus

strain/ painful strain during bowel movement

98
New cards

Klebsiella pneumoniae

immune compromised

99
New cards

Lobar pneumonia

other name for Klebsiella pneumoniae

100
New cards

Inhalation of aerosolized droplets containing the bacterium; Often affects individuals with weakened immune systems, alcoholics, diabetics, or those with chronic lung disease

Portal of Entry of Klebsiella pneumoniae: